Major Decisions On How NCI Will Spend Extra Money Won’t Be Made for Three-Four Months
In Brief: Twenty-Nine Percent Of Approved Organ Systems Applications Funded In February, May Cycles
Consensus Conference agrees That Nevi Can Be Precursors For Melanoma, Offers Management Suggestions
DCBD Board Rejects Breast Cancer Multiple Markers Concept Proposal
DRCCA Board Gets Tough on Concept Proposals, Okays Several Anyway
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- The end of “more money, more people, more trials”
Cancer centers are being asked to grow their portfolios on flat budgets. Headcount is the wrong answer. - Harold Freeman, a surgeon who championed health equity, dies at 93
Freeman, the father of patient navigation, served as president of ACS and chair of the President’s Cancer Panel - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish
